702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797630735490744320 |
|---|---|
| author | Zhonglin Hao Alberto Chiappori Adam Schoenfeld Paul Schwarzenberger Jacob Sands Lida Pacaud Christopher delCorral Dong Geng Zhong Yun Chaun Wang Gianni Amato Sahista Vahora |
| author_facet | Zhonglin Hao Alberto Chiappori Adam Schoenfeld Paul Schwarzenberger Jacob Sands Lida Pacaud Christopher delCorral Dong Geng Zhong Yun Chaun Wang Gianni Amato Sahista Vahora |
| author_sort | Zhonglin Hao |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:12:21Z |
| format | Article |
| id | doaj.art-4560f577f2ab4103901046653b1ab56d |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:12:21Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-4560f577f2ab4103901046653b1ab56d2023-11-11T18:45:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0702702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancerZhonglin Hao0Alberto Chiappori1Adam Schoenfeld2Paul Schwarzenberger3Jacob Sands4Lida Pacaud5Christopher delCorral6Dong Geng7Zhong Yun8Chaun Wang9Gianni Amato10Sahista Vahora11Aff1 0000 0001 2284 9329grid.410427.4Georgia Cancer Center at Augusta University Augusta GA USA1Moffitt Cancer Center, Tampa, FL, USADepartment of Medicine, Weill Cornell Medical College, New York, NY, USA9Merck and Co., Inc., Kenilworth, NJ, USADana-Farber Cancer Institute, Boston, Massachusetts, USA6 Legend Biotech USA Inc, Piscataway, New Jersey, USA3Legend Biotech, Somerset, NJ, USA3Legend Biotech, Somerset, NJ, USA3Legend Biotech, Somerset, NJ, USA3Legend Biotech, Somerset, NJ, USA3Legend Biotech, Somerset, NJ, USA3Legend Biotech, Somerset, NJ, USA |
| spellingShingle | Zhonglin Hao Alberto Chiappori Adam Schoenfeld Paul Schwarzenberger Jacob Sands Lida Pacaud Christopher delCorral Dong Geng Zhong Yun Chaun Wang Gianni Amato Sahista Vahora 702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer Journal for ImmunoTherapy of Cancer |
| title | 702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer |
| title_full | 702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer |
| title_fullStr | 702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer |
| title_full_unstemmed | 702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer |
| title_short | 702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer |
| title_sort | 702 phase 1 study of dll3 directed chimeric antigen receptor t cells in subjects with extensive stage small cell lung cancer |
| work_keys_str_mv | AT zhonglinhao 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT albertochiappori 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT adamschoenfeld 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT paulschwarzenberger 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT jacobsands 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT lidapacaud 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT christopherdelcorral 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT donggeng 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT zhongyun 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT chaunwang 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT gianniamato 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer AT sahistavahora 702phase1studyofdll3directedchimericantigenreceptortcellsinsubjectswithextensivestagesmallcelllungcancer |